Your cart is currently empty!
Australia – December 19, 2024
Clueo Clinical, a leader in clinical research training, is proud to announce its recognition as the ‘Most Innovative Clinical Research Training Enterprise 2024 – Australia’ by Global Health & Pharma (GHP) Magazine, UK. This prestigious award highlights Clueo Clinical’s groundbreaking efforts in bridging the gap between academic qualifications and industry demands, particularly in underserved communities, including regional, rural, and remote areas and developing countries.
The Healthcare & Pharmaceutical Awards have been shining a spotlight on the outstanding achievements of individuals and organisations across the global healthcare and pharmaceutical sectors since 2010. These awards recognise the excellence of enterprises that continue to elevate our experience of health and wellbeing, from physical to mental health. We are proud to be part of this distinguished group, where Clueo Clinical’s work in empowering underserved communities stands out. As an award-winning company, Clueo Clinical is playing a pivotal role in addressing the clinical research workforce shortage and providing career opportunities in regions often overlooked, including rural, remote, and war-torn areas. Through its Industry-Bridging Program (IBP), Clueo Clinical is fostering innovation and inclusivity by training a diverse, skilled workforce, ultimately contributing to improved healthcare outcomes and advancing global research efforts. As Kaven Cooper, the Awards Coordinator, aptly stated, this year’s winners embody “compassion,” “care,” and “innovation”—values that align perfectly with Clueo Clinical’s mission to change lives and drive progress in the clinical research field.
Pioneering Industry-Bridging Program
At Clueo Clinical, innovation means empowering people. Through its flagship Industry-Bridging Program (IBP), the company equips STEM-qualified candidates with practical skills, knowledge, and confidence to excel in the clinical research field. By addressing critical workforce shortages and expanding access to industry-aligned training, Clueo Clinical accelerates clinical trials and enhances patient outcomes in areas that need it the most.
A Message from the Founder and CEO
“We’re thrilled to receive this recognition, which validates our mission to advance clinical research through targeted, human-centered training programs,” said Dr. Thu (Sue) Nguyen, Founder and CEO of Clueo Clinical.
“Innovation isn’t just about developing new drugs or devices. It’s about solving diverse challenges within the clinical research ecosystem with fresh ideas and creative solutions. Building a skilled, confident workforce is essential for driving progress and creating meaningful, lasting change,” Dr. Nguyen added.
A Commitment to Global Impact
Clueo Clinical is dedicated to shaping the future of clinical research by empowering professionals, fostering diversity, and improving global access to opportunities. This award underscores the company’s commitment to sustainable, impactful solutions that address skills gaps and advance healthcare innovation. into industry-ready talent while supporting companies in building high-performing teams that accelerate clinical trials and improve patient outcomes.
Learn more: www.clueoclinical.com
Contact us: info@clueoclinical.com | +61 1300 39 22 06
For media inquiries, please contact:
Dr. Thu (Sue) Nguyen
Founder and CEO
sue.nguyen@clueoclinical.com
To learn more about the award and see the full list of winners, visit the official Global Health & Pharma Awards page and Clueo Clinical award page.